Brought to you by 
Cardior brings in €15mm via Series A
12 May 2017
Executive Summary
Cardior Pharmaceuticals GMBH (cardiovascular drugs and companion diagnostics) raised €15mm ($16.3mm) in its Series A financing led by Life Sciences Partners, Boehringer Ingelheim Venture Fund, Bristol-Myers Squibb, BioMedPartners, and High-Tech Gründerfonds.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cardior brings in €15mm via Series A
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice